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ABSTRACT. Following transcatheter arterial chemoembolisation (TACE), the
appearances on CT or MR images are largely related to the chemical and ischaemic
insults to the portal tract. Understanding the mechanism of TACE-induced changes is
essential for radiologists in order to determine the therapeutic effect as well as to
distinguish these changes from recurrent tumours. This pictorial review illustrates the
haemodynamic and substantial parenchymal changes related to TACE for hepatic
malignancy.
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Portal venous perfusion is essential for the function
and survival of hepatocytes, whereas the hepatic artery
primarily supplies the hepatic framework of the portal
tract. Almost all hepatic tumours receive their blood
supply from the hepatic artery (Figure 1) [1, 2]. Although
several therapeutic options have been advocated, trans-
catheter arterial chemoembolisation (TACE) has been
widely used for hypervascular hepatocellular carcino-
mas (HCCs) as an effective and palliative treatment [3].
Despite technical efforts to achieve highly selective
embolisation of the tumour-supplying vessels, small or
large insults to the non-tumorous parenchyma are
inevitably induced by the embolic materials or procedure
itself. In addition to functional problems, the various
imaging appearances of the TACE-induced parenchymal
injury have presented a challenge when determining the
therapeutic effect or distinguishing this parenchymal
injury from the viable tumour. In this article, we review
the TACE-induced haemodynamic and parenchymal
changes and illustrate their CT and MRI features.
Protocols for TACE and follow-up
Our routine protocol for TACE includes the admin-
istration of an emulsion consisting of 1–20 ml of iodised
oil (lipiodol; Andre-Guerbet, Aulnay-Sous-Bois, France)
and 10–50 mg of doxorubicin (Adriamycin; Kyowa
Hakko Kogyo, Tokyo, Japan), with the dose depending
on the size, extent and vascularity of the tumour. If
possible, the emulsion is injected exclusively into the
tumour-feeding segmental or subsegmental arterial
branches. This is followed by administration of gelatin
sponge (Gelfoam; Upjohn, Kalamazoo, MI) fragments
[3, 4]. The first follow-up CT is performed three or four
weeks after TACE, and further follow-up CT examina-
tions are performed three months and six months after
TACE (Figure 2). If there is no evidence of recurrence of
HCC in the six months following TACE, a-fetoprotein
levels should be checked every three months and
follow-up CT should be taken every year. Repeat
TACE or radiofrequency ablation is recommended for
residual tumour, marginal recurrence, intrahepatic
metastases or newly developed lesions with arterial
enhancement and venous washout on follow-up CT.
MRI is needed for artefacts from dense lipiodol
accumulation and arterial hypervascular pseudolesions
from perfusion variation, and a technical limitation such
as unoptimised arterial phase imaging for follow-up CT.
Repeat TACE is performed for the HCC recurrence seen
on MRI, and cases with no recurrence require routine
follow-up CT examinations.
Bile duct injuries
Bilomas are the most common type of biliary compli-
cation after TACE [5]. The incidence of bile duct injury
was significantly higher in patients with non-advanced
cirrhotic liver, those undergoing highly selective embo-
lisations and those with a history of repeated TACE
procedures [6]. In acute-stage bile duct injury, necrosis of
the bile ductule followed by rupture may lead to biloma
formation, with or without secondary infection, and
abscess formation, which may require an urgent drai-
nage procedure (Figures 3 and 4). Stricture and dilata-
tion of the bile duct are indicative of chronic-stage bile
duct injury (Figure 3).
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Portal vein obliteration
In addition to the direct chemical and ischaemic insults
by the embolic agents via the vasa vasorum or periportal
capillary plexus, extravasated bile from the disruption of
the necrotised bile duct can track along the sheaths of
Glisson capsule and result in portal phlebitis and
compromised vascular patency [4, 7]. There is also the
possibility that the dilated bile duct proximal to the
stricture site will gradually compress the adjacent portal
vein branches in the injured portal tract (Figures 3–5).
Gross appearance of large intrahepatic bile duct injury
tends to be followed by obliteration of the adjacent portal
vein (Figure 5). Bile duct dilatations usually appear within
one month after TACE, and most of the portal vein
obliteration appears one to six months after TACE [4].
Acute parenchymal infarct
Owing to the intra-arterially infused chemoembolic
materials, the period of stasis of arterial flow depends on
the arterial diameter, the development of collateralisa-
tion and the total amount and density of embolic
materials used. Embolic materials flow into the portal
venules through the transplexal route, which leads to
obliteration of the portal venules [7]. In the above
conditions, the simultaneously decreased arterial and
portal venous perfusion results in parenchymal infarc-
tion, which appears as a low-density area on all phases of
dynamic CT (Figure 6). During the follow-up periods,
some arterial inflow can be recovered by arterial
recanalisation or collateralisation (Figure 7). Arterial
reperfusion of previously infarcted parenchyma can
demonstrate inhomogeneous enhancement on arterial
phase images. Owing to the decreased attenuation of the
infarcted area on pre-contrast and equilibrium-phase
images, it can be hard to differentiate the reperfused area
from a viable tumour that shows subsequent washout of
contrast material. Super-
paramagnetic iron oxide particle (SPIO) uptake is also
decreased in the infarcted parenchyma in the vicinity of
the lesion (Figure 8).
Arterioportal fistulae
After TACE, chemical or ischaemic injury of the portal
tract and direct mechanical injury of the arterial wall by
the guide wire or catheter itself can induce the formation
Figure 1. Schematic anatomy of normal hepatic vessels. The
hepatic artery (A) primarily supplies the hepatic framework
of the portal tract, which consists of the portal vein (P), bile
duct (B) and hepatic artery. There are capillary networks
between the hepatic artery (A) and portal vein (P), which is
called the peribiliary plexus (pbp), and the portal venous
flow affords sinusoidal (s) perfusion, supplying the hepato-
cytes (h). V, hepatic vein.
Figure 2. Flowchart of follow-up CT examinations and MRI after transcatheter arterial chemoembolisation (TACE).
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Figure 3. Schemata of acute and chronic transcatheter arterial chemoembolisation (TACE)-induced bile duct injury and portal
vein obliteration, with or without parenchymal infarct. (a) In the acute stage, necrosis of the bile duct induces rupture of the bile
duct and biloma formation (asterisks) along the portal tract. A large cystic biloma can occupy the space of the acutely infarcted
parenchyma. (b) In the chronic stage, the portal tract injury with stricture and dilatation of the bile ducts is accompanied by
gradual portal vein obliteration, resulting in parenchymal atrophy.
(a) (b)
Figure 4. A 50-year-old man with underlying diabetes mellitus (DM) shows transcatheter arterial chemoembolisation (TACE)-
induced portal tract and parenchymal injury, consisting of infarct and biloma formation with secondary infection by air-forming
bacteria. (a) Before TACE, the portal vein branch in segment 4 (arrow) is well demonstrated on the portal phase of post-contrast
CT. (b) On the 1 month follow-up CT after TACE, portal phase CT reveals an area with the density of air, which is a necrotic portal
tract (arrow) that is associated with adjacent subcapsular fluid collection, suggesting biloma (arrowheads).
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Figure 5. A 51-year-old man shows transcatheter arterial chemoembolisation (TACE)-induced bile duct injury. (a) On the
1 month follow-up CT after TACE, portal phase CT shows low density (arrow) alongside the portal vein branch, suggesting bile
duct injury. (b) On the 8 month follow-up CT after TACE, portal phase CT demonstrates further progression of the bile duct
injury with proximal bile duct dilatation (arrow) and chronic stricture of the distal bile duct in the lateral segment of the left
lobe of liver.
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Figure 6. A 60-year-old woman with biloma formation after transcatheter arterial chemoembolisation (TACE). (a) On the portal
phase CT scan, the branching pattern of the biloma (arrowheads) is shown 3 weeks after TACE. (b) Below the level of (a), the
portal phase of dynamic CT shows linear biloma formation (arrowheads) along the right posterior segmental branch of the the
portal vein (arrow). (c) On the 3 month follow-up CT after TACE, portal phase imaging depicts obliteration of the portal vein
(arrow) and delayed infarction with decreased perfusion (arrowheads) in the posterior segment of the right lobe of the liver. (d)
On the 7 month follow-up CT after TACE, the obliterated portal vein branch (arrow) and the atrophic change (arrowheads) in
the posterior segment of the right lobe of liver is shown in the portal phase.
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Figure 7. A 63-year-old woman with parenchymal infarction after transcatheter arterial chemoembolisation (TACE). (a) Schema
of acute infarction after TACE. Embolic materials flow into the portal venules and lead to obliteration of portal venules. At the
same time, decreased perfusion results in parenchymal infarct. (b) A CT scan, obtained 3 weeks after TACE, shows wedge-
shaped, non-enhancing low density intermingled with high-density iodised oil, suggesting subsegmental parenchymal
infarction (arrowheads). (c) 2 months after TACE, marked atrophic change (arrowheads) at the area corresponding to
parenchymal infarct is noted on the portal phase CT.
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Figure 8. A 65-year-old man with a perilesional infarct around the treated hepatocellular carcinoma (HCC), with iodised oil
accumulation after transcatheter arterial chemoembolisation (TACE). (a) Pre-contrast CT image reveals decreased density (arrow)
at the parenchymal retraction area on the anterior aspect of the iodised oil-accumulated lesion (arrowhead). (b) Arterial phase
of dynamic MRI shows nodular enhancement (arrow) adjacent to the iodised oil lesion (arrowhead). (c) Decreased uptake of
superparamagnetic iron oxide particles (SPIOs) (arrow) at the area of arterial enhancement on SPIO-enhanced T2* weighted
gradient-echo MRI. High signal intensity of the small iodised oil accumulation (arrowhead) is not distinguishable from the
adjacent infracted/atrophic parenchyma (arrow). (d) 9 month follow-up CT shows further contraction of the atrophic
subsegment (arrow) on the anterior aspect of the iodised oil lesion (arrowhead) without any evidence of recurrent HCC.
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Figure 9. A 49-year-old woman with transcatheter arterial chemoembolisation (TACE)-induced arterioportal fistula formation.
(a) Schema of a TACE-induced fistula. TACE-related portal tract injury can induce fistula formation between the small peripheral
hepatic artery and the portal vein branches. Owing to the higher arterial perfusion pressure, the gross arterioportal shunt
(asterisk) locally replaces the portal venous perfusion. (b) Arterial phase image of dynamic CT taken 3 months after TACE reveals
the portal vein branch (arrow) and wedge-shaped parenchymal perfusion (arrowheads) from the arterioportal shunt through
the arterioportal fistula in the vicinity of the dense iodised oil accumulation area (asterisk). (c) 9 months after TACE, gross
appearance of the portal vein branch is not noted and the extent of parenchymal enhancement (arrowheads) is diminished on
the arterial phase dynamic CT (asterisk indicates dense iodised oil accumulation area). (d) TACE-induced arterioportal shunt is no
longer demonstrated on the 1 year follow-up CT (asterisk indicates dense iodiset oil accumulation area). (e) Dynamic MRI
obtained at 13 week follow-up shows a wedge-shaped arterial enhancement (arrowheads) adjacent to the iodised oil
accumulation site (asterisk). (f) The arterial enhancing area is not distinguished from background parenchyma on the
superparamagnetic iron oxide particle-enhanced T2* weighted gradient-echo MRI obtained at 13 week follow-up after TACE
(asterisk indicates dense iodised oil accumulation area).
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Figure 10. A 54-year-old man with transcatheter arterial chemoembolisation (TACE)-induced arterioportal shunt, portal vein
obliteration and infarct. (a) Arterial phase dynamic CT depicts an amorphous enhancement (arrows) in the left lobe of the liver
and subsegmental atrophy with partial iodised oil accumulation (arrowheads) at segment 8. (b) On dynamic MRI, arterial
enhancement in the left lobe of the liver represents the TACE-induced arterioportal shunt (arrows). Decreased perfusion at S8
indicates infarction (arrowheads). (c) Superparamagnetic iron oxide particle (SPIO)-enhanced delayed MR image shows normal
SPIO uptake at the arterioportal shunt area and decreased SPIO uptake at the infarcted area (arrowheads).
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Figure 11. A 77-year-old man with a hypervascular pseudolesion around the treated nodular hepatocellular carcinoma (HCC),
with dense iodised oil accumulation. (a) On arterial phase dynamic CT, nodular arterial enhancement (arrowhead) abutting to
the iodised oil accumulation is suggestive of marginal recurrence of HCC. (b) Inhomogeneouly decreased density at the arterial
enhancing area looks like the washout appearance (arrowhead) of hypervascular HCC on the portal phase dynamic CT. (c) On
superparamagnetic iron oxide particle SPIO-enhanced T2* weighted gradient-echo MRI, the hypervascular lesion shows normal
SPIO uptake in the anterior aspect of the pre-existing iodised oil accumulation area (arrowhead).
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of a fistula between small arteries and the portal vein
branches alongside [8]. Typically, subcapsular, wedge-
shaped or irregular arterial phase enhancement during
dynamic CT or MRI could be regarded as an arterio-
portal fistula (APF) (Figures 9 and 10). Owing to the
traumatic or acute inflammatory nature of this injury,
most traumatic APFs would disappear on the serial
follow-up imaging studies (Figure 9). In the advanced
cirrhotic liver, differential diagnosis of APF from
recurrent HCC is sometimes difficult because of the
parenchymal distortion and inhomogeneous attenuation
of the background liver on delayed-phase images
(Figure 11). MRI using Kupffer cell agent (SPIO) is
helpful for excluding a true tumour from an acute
APF-induced arterioportal shunt that shows normal
SPIO uptake (Figure 11) [9].
Parenchymal atrophy
Parenchymal atrophy occurs because of decreased
portal venous perfusion following acute or gradual
vascular compromise caused by bile duct injury, arterial
vasculitis, portal phlebitis and/or passive compression
(Figures 5, 6, 8 and 10) [4, 10]. Depending on the extent
of involvement, TACE-induced parenchymal atrophy in
the cirrhotic liver, in which portal venous inflow is
already decreased by portal hypertension, may deterio-
rate liver function. Yu et al [4] reported the mean time
between TACE and the appearance of atrophic changes
as 20 weeks.
Conclusions
After TACE, the appearances on CT or MRI are largely
related to the chemical and ischemic insults to the portal
tract. The mechanism and imaging findings of TACE-
induced changes should be familiar to radiologists, so
that they can determinate the therapeutic effect as well as
distinguish such changes from a recurrent tumour. Serial
follow-up is still essential and selective application of
liver-specific contrast-enhanced MRI is recommended
for accurate assessment of relevant conditions.
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